Tests drugs on a patient's fresh tumor tissue to see what actually responds.
Consented intake · your records travel with you · nothing moves without your sign-off
First Ascent Biomedical performs functional testing: applying drugs to fresh tumor tissue and observing the response, with turnaround from two days to six weeks. The goal is greater confidence that a patient will respond to a drug or combination before committing to it. Getting fresh tumor tissue can be a limitation, so timing matters for patients considering this option.
Prefer the source? First Ascent Biomedical's own site has more.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how First Ascent Biomedical handles billing.
We don't have confirmed insurance details for First Ascent Biomedical yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in First's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Gather distinctive biomarkers that can guide treatment and monitor disease progression
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Finds clinical trials you actually qualify for — matched to your tumor's biomarkers and treatment history, not a generic keyword search.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.